Bonatra, a holistic health start-up that offers a unified health stack solution to treat, manage, and reverse chronic diseases, has acquired women’s health and wellness company MyAva. Through this acquisition, Bonatra aims to expand its holistic healthcare programs and become a one-stop platform for the management of chronic health conditions.
 |
| Bonatra founders (L-R) Seated — Amit Acharya, Manjari Chandra, Ramanpreet Singh and standing Rahul Kishore Singh |
MyAva is a femtech startup that empowers women to manage chronic health conditions such as polycystic ovary syndrome (PCOS), thyroid disorders, insulin resistance, and more. The company was founded in 2019 by Evelyn Immanuel, and it has since established itself as a trusted provider of curated programs and personalized plans that help women improve their health and wellbeing.
Bonatra is a doctor-led IoMT (Internet of Medical Things) start-up focused on treating and managing chronic diseases such as diabetes, Hypertension, fatty liver, PCOD, Obesity etc.. Bonatra uses personalised treatment, which is arrived at after analysing multiple data points and health parameters using various easy-to-use IoMT devices. Founded in April 2022 by Rahul Kishore Singh(CEO), Manjari Chandra(CMO), Ramanpreet Singh(COO) and Amit Acharya(CTO), Bonatra integrates clinical acumen with technology to achieve holistic health. The solutions at Bonatra include personalised, targeted lifestyle, nutritional and fitness interventions to balance hormones, and supplementing it with other functional methods of gut reset, correcting gut dysbiosis(imbalance in gut bacteria), and harnessing natural detox procedures to reduce heavy metal toxicity in the body.
Commenting on the acquisition, Rahul Kishore Singh, CEO and Co-Founder, Bonatra, said, “We are thrilled to welcome MyAva to join the Bonatra family. Acquiring MyAva enables us to expand our reach and deepen our expertise in women’s health, specifically for conditions like PCOS. We have been closely working with and interacting with the MyAva team and we believe that this will be a good strategic fit for Bonatra. Our mission is to empower people to take proactive measures to prevent, manage, and reverse chronic health conditions. This move will further strengthen our expertise in holistic healthcare solutions.”
Evelyn Immanuel, Founder and CEO, MyAva, said, “MyAva is elated to join Bonatra and further the vision of making chronic care management accessible to all women. We believe this further strengthens our combined commitment towards making femtech more inclusive and integrated.”
Commenting on the acquisition, Yagnesh Sanghrajka, Founder and CFO, 100X. VC said, “I am confident that Bonatra’s acquisition of MyAva is a move in the right direction and it will further enhance the company’s offering. Bonatra's expansion into women's health and wellness through the acquisition of MyAva will solidify its position as a leading player in the healthcare industry. The combination of Bonatra's personalized treatment approach and MyAva's trusted programs and plans for managing chronic health conditions in women addresses a large unmet need in the market. I look forward to seeing the continued growth and success of Bonatra with this new addition to their platform. Wishing both the teams success in their joint endeavour and scaling new peaks''
Over the next six months, Bonatra has plans to introduce newer IoMT devices including a smart ring in the Indian market to further strengthen its solutions which are a convergence of medical science, data science and technology.
Very recently, the company raised 5.5 Crores in a Pre-Seed Round round led by ITI Growth Opportunities Fund with participation from marquee angel investors like Jitendra Jagadev, Founder, Nestaway and Helloworld, and Rajesh Yabaji, Founder, Blackbuck
About Bonatra:
Bonatra is an IoMT based holistic health start-up creating a convergence of medical science, data science and technology to help people manage and reverse chronic metabolic diseases and improve their lifestyles, all from the comfort of their homes. Bonatra’s approach uses personalised treatment, which is arrived at after analysing multiple data points and health parameters using various easy-to-use IOMT devices.For more details, visit: www.bonatra.com
Advertisements